Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials.

Lina TaoXiaoyu QuYue ZhangYanqing Song Si-Xi Zhang

Published in: Canadian journal of gastroenterology & hepatology (2019)

Prophylactic therapy of silymarin is contributed to a noticeably reduced risk of development of anti-TB DILI four weeks after the initiation. In addition, silymarin significantly improved the liver function in patients who are receiving anti-TB drugs.

Keyphrases

mycobacterium tuberculosis
drug induced
systematic review
emergency department
stem cells
adverse drug
cell therapy
replacement therapy